0001493152-19-003665.txt : 20190320
0001493152-19-003665.hdr.sgml : 20190320
20190320172407
ACCESSION NUMBER: 0001493152-19-003665
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190320
DATE AS OF CHANGE: 20190320
EFFECTIVENESS DATE: 20190320
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000830656
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 042652826
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-335342
FILM NUMBER: 19695336
BUSINESS ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
BUSINESS PHONE: 5082301828
MAIL ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
FORMER COMPANY:
FORMER CONFORMED NAME: BOSTON BIOMEDICA INC
DATE OF NAME CHANGE: 19960812
D
1
primary_doc.xml
X0708
D
LIVE
0000830656
PRESSURE BIOSCIENCES INC
14 NORFOLK AVENUE
SOUTH EASTON
MA
MASSACHUSETTS
02375
(508)230-1828
MASSACHUSETTS
None
BOSTON BIOMEDICA INC
Corporation
true
Richard
T.
Schumacher
14 Norfolk Avenue
South Easton
MA
MASSACHUSETTS
02375
Executive Officer
Director
President, Chief Executive Officer, Treasurer and Clerk
Richard
P.
Thomley
14 Norfolk Avenue
South Easton
MA
MASSACHUSETTS
02375
Executive Officer
Acting Chief Financial Officer
Kevin
A.
Pollack
14 Norfolk Avenue
South Easton
MA
MASSACHUSETTS
02375
Director
Vito
J.
Mangiardi
14 Norfolk Avenue
South Easton
MA
MASSACHUSETTS
02375
Director
Michael
S.
Urdea
14 Norfolk Avenue
South Easton
MA
MASSACHUSETTS
02375
Director
Chairman of the Board
Jeffrey
N.
Peterson
14 Norfolk Avenue
South Easton
MA
MASSACHUSETTS
02375
Director
Chairman of the Board
Biotechnology
$1,000,001 - $5,000,000
- 06b
false
2018-05-02
true
true
true
true
false
0
None
None
Garden State Securities, Inc.
10083
328 NEWMAN SPRINGS ROAD
RED BANK
NJ
NEW JERSEY
07701
All States
false
Indefinite
17459551
Indefinite
From May 2, 2018 through March 6, 2019, the Company sold the securities detailed in Item 9 for a total purchase price of $4,288,000. During the same period, the company converted debt equal to $13,171,551 into the securities detailed in Item 9.
false
43
416300
0
Warrants for 318,680 shares with an exercise price of $3.50 per share were issued to Garden State as compensation in addition to their sales commissions.
0
true
false
PRESSURE BIOSCIENCES INC
/s/ Richard T. Schumacher
Richard T. Schumacher
President, CEO, Treasurer, Clerk and Director
2019-03-20